Zenodo
Which biologic is safer for a patient with rheumatoid arthritis and MGUS?
By Tripdatabase.
Abstract
No direct evidence for the safety of biologics in patients with rheumatoid arthritis and MGUS was identified. General RA safety data suggest close monitoring is crucial, with abatacept potentially offering a favorable profile.
Keywords
- Rheumatoid Arthritis Research and Therapies
- rheumatoid arthritis
- monoclonal gammopathy of undetermined significance
- biologic therapy safety
- abatacept
- pharmacovigilance
- Open access
Source
Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.